SynPlexity is a Eugene company, based at the University of Oregon’s Knight Campus. It was cofounded by Knight Campus bioengineering professor Calin Plesa. And it was a University of Oregon spinout and a Launch Oregon portfolio company. Well, today, Azenta announced that it has acquired SynPlexity.
Azenta has also acquired SynPlexity, adding pooled gene assembly technology that provides thousands of full-length gene variants in a single library. These capabilities address the increasing scale of biological design by enabling researchers to efficiently build and test large numbers of candidates, including AI-generated designs.
The deal is part of what Azenta calls strategic investments in its GENEWIZ business, alongside an exclusive license with Elegen. Terms weren’t disclosed. Azenta says more details are coming on its fourth quarter fiscal 2026 earnings call.
For more, read the announcement from Azenta.
Silicon Florist on Patreon
Join 138 patrons supporting Portland startup coverage
Want even more?Includes an absolutely and totally FREE tier
